The Effect of Multidisciplinary Brief Intervention on Reduction of Cardio- Metabolic Risk Factors

Not Applicable

Recruiting

• Conditions: Cardio-metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20150919024080N21
• Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

Women with metabolic heart disease aged 18 - 75
Patient with moderate to high risk and with two risk factor of cardiometabolic according to risk assessment scale (prediabetic situation or metabolic syndrome)
Exposure in the level of 3, 4, 5 ESI triage
Ability to understand andperception Persian language
Willingness and consent to participate in research and to complete the form of research ethics
Admission and accommodation in the emergency department for at least 24 hours and having a medical record
Psychological disorder, such as severe mood disorders
BMI>27 (in the weight of overweight and obese)
On average , more than 60 minutes per week physical activity (moderate and severe) has occurred over the past three months
Having a fixed phone or cell phone

Exclusion Criteria

getting with a severe psychological illness after the diagnosis of the disease.
the present experience of cardiovascular disease like dyspnea or tachycardia
Chronic diseases such as renal failure , liver failure
getting viral disease and acute infected disease such as covid 19
Patients at the risk of suicide according to the Nurses Global Assessment of Suicide Risk criteria .
Heart Rate<60 AND Heart Rate>100
Systolic Blood Pressure>160 AND Diastolic Blood Pressure>100
Engagement in other counseling programs and changing behavior for lifestyle
hospitalization for more than a week

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiometabolic risk. Timepoint: Before starting treatment and after completing the 60 day treatment period. Method of measurement: FINDRISK tool.;Physical activity. Timepoint: Before starting treatment and after completing the 60 day treatment period. Method of measurement: Short International Physical Activity questionnaire.;Mediterranean diet score. Timepoint: Before starting treatment and after completing the 60 day treatment period. Method of measurement: Modified Mediterranean diet score questionnaire.